Acute appearance of fatty acids in human plasma - A comparative study between polar-lipid rich oil from the microalgae Nannochloropsis oculata and krill oil in healthy young males

Lipids in Health and Disease

Volumn 12, Issue 1, 2013, Pages

  Kagan, Michael L ^a   West, Annette L ^b   Zante, Christa ^c   Calder, Philip C ^b  

^a Qualitas Health Ltd   (Israel)

^b UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

^c MPS Hamburg GmbH   (Germany)

Author keywords

Algal oil; Docosahexaenoic acid; Eicosapentaenoic acid; Glycolipids; Krill oil; Omega 3; Phospholipids; Polar lipids

Indexed keywords

DOCOSAHEXAENOIC ACID; FATTY ACID; ICOSAPENTAENOIC ACID; KRILL OIL; LIPID; POLAR LIPID; UNCLASSIFIED DRUG; VEGETABLE OIL;

ADULT; AREA UNDER THE CURVE; ARTICLE; BLOOD SAMPLING; CONTROLLED STUDY; DIET SUPPLEMENTATION; DRUG BLOOD LEVEL; FATTY ACID BLOOD LEVEL; FOOD INTAKE; GAS CHROMATOGRAPHY; HUMAN; HUMAN EXPERIMENT; KRILL; LIPID DIET; MALE; MEAL; MICROALGA; NANNOCHLOROPSIS OCULATA; NORMAL HUMAN; PLASMA;

ADOLESCENT; ADULT; ANIMALS; DIET, HIGH-FAT; DOCOSAHEXAENOIC ACIDS; EICOSAPENTAENOIC ACID; EUPHAUSIACEA; FATTY ACIDS, OMEGA-3; HUMANS; LIPIDS; MALE; MICROALGAE; MIDDLE AGED; YOUNG ADULT;

ALGAE; EUPHAUSIACEA; NANNOCHLOROPIS; NANNOCHLOROPSIS OCULATA;

EID: 84880097003     PISSN: None     EISSN: 1476511X     Source Type: Journal    
DOI: 10.1186/1476-511X-12-102     Document Type: Article

References (40)

1. Understanding omega-3 polyunsaturated fatty acids. Calder PC, Yaqoob P, Postgrad Med J 2009 121 148 157
2. Conversion of alpha-linolenic acid to longer-chain polyunsaturated fatty acids in human adults. Burdge GC, Calder PC, Reprod Nutr Dev 2005 45 581 597 10.1051/rnd:2005047 16188209 (Pubitemid 41511883)
3. Haemostatic function and platelet poly unsaturated fatty acids in Eskimos. Dyerberg J, Bang HO, Lancet 1979 ii 433 435 (Pubitemid 9250399)
4. Eicosapentaenoic acid and prevention of thrombosis and atherosclerosis. Dyerberg J, Bang HO, Stoffersen E, Moncada S, Vane JR, Lancet 1978 ii 117 119 (Pubitemid 8373454)
5. Omega-3 fatty acids and cardiovascular disease: effects on risk factors, molecular pathways, and clinical events. Mozaffarian D, Wu JH, J Am Coll Cardiol 2011 58 2047 2067 10.1016/j.jacc.2011.06.063 22051327
6. Fish in-take, contaminants, and human health: evaluating the risks and the benefits. Mozaffarian D, Rimm EB, JAMA 2006 296 1885 1899 10.1001/jama.296.15.1885 17047219 (Pubitemid 44596197)
7. Marine n-3 poly unsaturated fatty acids and coronary heart disease. Part I. Background, epidemiology, animal data, effects on risk factors and safety. Schmidt EB, Arnesen H, de Caterina R, Rasmussen LH, Kristensen SD, Thromb Res 2005 115 163 170 10.1016/j.thromres.2004.09.006 15617737 (Pubitemid 40036611)
8. Bioavailability of marine n-3 fatty acid formulations. Dyerberg J, Madsen P, Møller JM, Aardestrup I, Schmidt EB, Prostagland Leukotr Essent Fatty Acids 2010 83 137 141 10.1016/j.plefa.2010.06.007
9. Association of marine omega-3 fatty acid levels with telomeric aging in patients with coronary heart disease. Farzaneh-Far R, Lin J, Epel ES, Harris WS, Blackburn EH, Whooley MA, JAMA 2010 303 250 257 10.1001/jama.2009.2008 20085953
10. N-3 polyunsaturated fatty acids in coronary heart disease: a meta-analysis of randomized controlled trials. Bucher HC, Hengstler P, Schindler C, Meier G, Am J Med 2002 112 298 304 10.1016/S0002-9343(01)01114-7 11893369 (Pubitemid 34219443)
11. n-3 fatty acids and lipoproteins: comparison of results from human and animal studies. Harris WS, Lipids 1996 31 243 252 10.1007/BF02529870 8900453 (Pubitemid 26094301)
12. Fatty acids and inflammation: the cutting edge between food and pharma. Calder PC, Eur J Pharmacol 2011 668 50 S58 21816146
13. Omega-3 polyunsaturated fatty acids and inflammatory processes: nutrition or pharmacology? Calder PC, Brit J Clin Pharmacol 2013 75 645 662
14. Addition of omega-3 fatty acid to maintenance medication treatment for recurrent unipolar depressive disorder. Nemets B, Stahl Z, Belmaker RH, Am J Psych 2001 159 477 479 (Pubitemid 34184747)
15. Meta-analysis of the effects of eicosapentaenoic acid (EPA) in clinical trials in depression. Sublette ME, Ellis SP, Geant AL, Mann JJ, J Clin Psych 2011 72 1577 1584 10.4088/JCP.10m06634
16. Oiling the brain: A review of randomized controlled trials of omega-3 fatty acids in psychopathology across the lifespan. Sinn N, Milte C, Howe PR, Nutrients 2010 2 128 170 10.3390/nu2020128 22254013
17. Omega-3 supplementation in mild to moderate Alzheimer's disease: effects on neuropsychiatric symptoms. Freund-Levi Y, Basun H, Cederholm T, Faxén-Irving G, Garlind A, Grut M, Vedin I, Palmblad J, Wahlund L, Eriksdotter-Jönhagen M, Int J Geriatr Psychiat 2008 23 161 169 10.1002/gps.1857 (Pubitemid 351308496)
18. Fish consumption, fish oil, omega-3 fatty acids, and cardiovascular disease. Kris-Etherton P, Harris WS, Appel LJ, American Heart Association Nutrition Committee, Circulation 2002 106 2747 2757 10.1161/01.CIR.0000038493. 65177.94 12438303 (Pubitemid 35364932)
19. Scientific Advisory Committee on Nutrition/Committee on Toxicity, Advice on fish consumption: Benefits and risks London: TSO 2004
20. Extraction and characterisation of lipids from Antarctic krill (Euphausia superba). Gigliottia JC, Davenport MP, Beamera SK, Toua JC, Jaczynski J, Food Chem 2011 125 1028 1036 10.1016/j.foodchem.2010.10.013
21. Screening of algae for potential alternative sources of eicosapentaenoic acid. Yongmanitchai W, Ward OP, Phytochem 1991 30 2963 2967 10.1016/S0031- 9422(00)98231-1
22. Crypthecodinium cohnii with emphasis on DHA production: a review. Mendes A, Reis A, Vasconcelos R, Guerra P, da Silva TL, J Appl Phycol 2009 21 199 214 10.1007/s10811-008-9351-3
23. Omega-3 fatty acids for nutrition and medicine: considering microalgae oil as a vegetarian source of EPA and DHA. Doughman SD, Krupanidhi S, Sanjeevi CB, Curr Diabetes Rev 2007 3 198 203 10.2174/157339907781368968 18220672 (Pubitemid 47244065)
24. Safety assessment of EPA-rich oil produced from yeast: Results of a 90-day subchronic toxicity study. MacKenzie SA, Belcher LA, Sykes GP, Frame SR, Mukerji P, Gillies PJ, Reg Toxicol Pharmacol 2010 58 490 500 10.1016/j.yrtph.2010.08.021
25. Elucidation of phosphatidylcholine composition in krill oil extracted from Euphausia superba. Winther B, Hoem N, Berge K, Reubsaet L, Lipids 2011 46 25 36 10.1007/s11745-010-3472-6 20848234
26. Health effects of dietary phospholipids. Küllenberg D, Taylor LA, Schneider M, Massing U, Lipids Health Dis 2012 11 3 10.1186/1476-511X-11-3 22221489
27. Incorporation of EPA and DHA into plasma phospholipids in response to different omega-3 fatty acid formulations-a comparative bioavailability study of fish oil vs. krill oil. Schuchardt JP, Schneider I, Meyer H, Neubronner J, von Schacky C, Hahn A, Lipids Health Dis 2011 10 145 10.1186/1476-511X-10-145 21854650
28. 2008 http://www.accessdata.fda.gov/scripts/fcn/gras-notices/grn000242.pdf
29. Production of EPA from the eustigamatophyte Nannochloropsis. Sukenik A, Chemicals from Microalgae Boca Raton: CRC Press, Cohen Z, 1999 41 53
30. A mutant of nannochloropsis deficient in eicosapentaenoic acid production. Schneider JC, Livne A, Sukenik A, Roessler PG, Phytochem 1995 40 807 814 10.1016/0031-9422(95)00365-E
31. Omega-3 fatty acids in inflammation and autoimmune diseases. Simopoulos AP, J Am Coll Nutr 2001 21 495 505
32. A dose-ranging study of the effects of ethyl-eicosapentaenoate in patients with ongoing depression despite apparently adequate treatment with standard drugs. Peet M, Horrobin DF, Arch Gen Psychiatr 2002 59 913 919 10.1001/archpsyc.59.10.913 12365878
33. Effects of eicosapentaenoic acid and docosahexaenoic acid on low density lipoprotein cholesterol and other lipids: a review. Jacobson TA, Glickstein SB, Rowe JD, Soni PN, J Clin Lipidol 2012 6 5 18 10.1016/j.jacl.2011.10.018 22264569
34. Incorporation of eicosapentaenoic and docosahexaenoic acids into lipid pools when given as supplements providing doses equivalent to typical intakes of oily fish. Browning LM, Walker CG, Mander AP, West AL, Madden J, Gambell JM, Young S, Wang L, Jebb SA, Calder PC, Am J Clin Nutr 2012 96 748 758 10.3945/ajcn.112.041343 22932281
35. Selective partitioning of dietary fatty acids into the VLDL TG pool in the early postprandial period. Heath RB, Karpe F, Milne RW, Burdge GC, Wootton SA, Frayn KF, J Lipid Res 2003 44 2065 2072 10.1194/jlr.M300167-JLR200 12923230 (Pubitemid 37509622)
36. Lack of effect of meal fatty acid composition on postprandial lipid, glucose and insulin responses in men and women aged 50-65 years consuming their habitual diets. Burdge GC, Powell J, Calder PC, Brit J Nutr 2006 96 489 500 16925854
37. Dietary fatty acids make a rapid and substantial contribution to VLDL-triacylglycerol in the fed state. Heath RB, Karpe F, Milne RW, Burdge GC, Wootton SA, Frayn KF, Am J Physiol Endocriniol Metab 2007 292 732 E739
38. Gurr MI, Harwood JL, Frayn KN, Lipid Biochemistry Oxford: Blackwell Science 5 2002
39. The effect of altering the 20:5n-3 and 22:6n-3 content of a meal on the postprandial incorporation of n-3 polyunsaturated fatty acids into plasma triacylglycerol and non-esterified fatty acids in humans. Burdge GC, Sala-Vila A, West AL, Robson HJL, Wilkinson Le Fevre L, Powell J, Calder PC, Prostagland Leukotr Essent Fatty Acids 2007 77 59 65 10.1016/j.plefa.2007.06.003 (Pubitemid 47248702)
40. Distribution, interconversion, and dose response of n-3 fatty acids in humans. Arterburn LM, Hall EB, Oken H, Am J Clin Nutr 2006 83 1467S 1476S 16841856 (Pubitemid 44713087)